Screener
Bioventus BVS Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $153.21M+3.8% | $132.09M+6.6% | $157.9M+2.8% | $138.65M-0.2% | $147.66M-2.4% | ||
| $47.54M+4.3% | $41.32M+1.2% | $49.12M-3.7% | $44.42M-2.2% | $45.57M-4.2% | ||
| $105.67M+3.5% | $90.77M+9.3% | $108.78M+6.0% | $94.23M+0.7% | $102.09M-1.5% | ||
| 69%-0.2pp | 68.7%+1.7pp | 68.9%+2.1pp | 68%+0.6pp | 69.1%+0.6pp | ||
| $3.17M0.0% | $2.47M-18.1% | $3.01M-8.1% | $2.92M-23.9% | $3.17M-24.7% | ||
| $82.74M+4.6% | $78.33M+6.6% | $82.76M-4.7% | $78.66M-3.5% | $79.11M-18.2% | ||
| $19.13M+4.1% | $8.42M+72.8% | $19.49M— | $11.25M+209% | $18.37M+158% | ||
| 12.5%0.0pp | 6.4%+2.4pp | 12.3%— | 8.1%+5.5pp | 12.4%+33.3pp | ||
| -$4.07M+45.7% | -$4.33M+42.4% | -$5.31M+41.0% | -$6.18M+35.2% | -$7.49M+24.5% | ||
| -$3.82M+52.6% | -$3.9M+52.9% | -$5.34M+31.1% | -$6.58M+26.1% | -$8.06M+20.1% | ||
| $15.31M+48.4% | $4.52M+232% | $14.14M+26,785% | $4.67M+189% | $10.31M+125% | ||
| -$20.9M-2,107% | $571K+701% | -$3.18M— | $664K+12.7% | $1.04M+114% | ||
| $33.44M+348% | $3.11M+218% | $14.76M+3,903% | $3.16M+161% | $7.46M+129% | ||
| 21.8%+16.8pp | 2.4%+4.5pp | 9.3%+9.6pp | 2.3%+6.0pp | 5.1%+22.0pp | ||
| $0.47+327% | $0.04+200% | $0.21— | $0.05+163% | $0.11+127% | ||
| $30.07M-1.1% | $19.62M+17.3% | $31.18M+829% | $22.66M+42.3% | $30.42M+265% | ||
| 19.6%-1.0pp | 14.9%+1.3pp | 19.7%+17.6pp | 16.3%+4.9pp | 20.6%+32.8pp | ||
| $19.13M+4.1% | $8.42M+72.8% | $19.49M+315% | $11.25M+209% | $18.37M+158% |
FAQ
- What is Bioventus's revenue?
- Bioventus (BVS) generated $581.8M in revenue over the trailing twelve months, up 3.1% year over year.
- Is Bioventus profitable?
- Bioventus reported $54.5M in net income over the trailing twelve months, a 9.4% net margin.
- What are Bioventus's profit margins?
- Gross margin is 68.7% and operating margin is 10.0%, with a 9.4% net margin.
- What is Bioventus's earnings per share?
- Bioventus's diluted EPS over the trailing twelve months is $0.77.
- Where does Bioventus's income statement data come from?
- Every line is extracted from Bioventus's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
